scorecardresearch

Covid-19: Mylab to ramp up production of test kits

Hasmukh Rawal, founder and managing editor, Mylab Discovery Solutions said, “Amid the surge of Covid cases in India, we have witnessed a 200% jump in sales of our self-test kit, CoviSelf, in December compared to November.”

Covid-19: Mylab to ramp up production of test kits
Covid-19-related tests are now contributing around 20-25% of the revenues of the Indian diagnostic industry.

An exponential growth in the number of Omicron cases and a faster transmitting variant have led to a rise in demand for Covid-19 testing kits. Pune-based Mylab Discovery Solutions has witnessed a 200% month-on-month jump in demand for self-test kit CoviSelf in December 2021.

CoviSelf can detect variants of coronavirus including Omicron. A similar surge has also been see in their RT-PCR test kit, PathoDetect, and the PathoDetect rapid antigen test kit.Hasmukh Rawal, founder and managing editor, Mylab Discovery Solutions said, “Amid the surge of Covid cases in India, we have witnessed a 200% jump in sales of our self-test kit, CoviSelf, in December compared to November.

Maharashtra, West Bengal, Rajasthan, Delhi and Andhra Pradesh are the top states where the demand for our kits is high. Mumbai followed by Delhi and Kolkata are the biggest buyers of the self-test kit ”. To meet this demand, the company is ramping up production of test kits. “For home-testing kits, we are already producing 10 lakh kits a day and can ramp up to 20 lakh tests a day if required,” Rawal said.

The production of PathoDetect has doubled in the last month and production has been ramped up from two lakh kits to four lakh kits a day, and the company can ramp it up further to 6 lakh if required, he said.Rawal said there was enough manufacturing capacity in the country and there would be no shortage of testing kits. There are about 40 manufacturers in the country making or developing RT PCR tests. 

Covid-19-related tests are now contributing around 20-25% of the revenues of the Indian diagnostic industry. Driven by the second wave, the footprint of pathology labs especially molecular diagnostics (RT-PCR) and self testing has grown.Mylab’s Covid-19 self-test kit has received regulatory approval and is getting into the US, Europe and Middle East markets.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

First published on: 07-01-2022 at 08:12:35 am